Inaktiver Wert

Termine Albireo Pharma, Inc.

Aktien

A2DF99

US01345P1066

ALBO

Terminchart Albireo Pharma, Inc.

92d3d037d9537ba8587776.FRqy27vw3nwrjU1E6yCsEVXM1R7FCaQNFZKPPCNTHYg.eEXEuti5tQ5t9ycPkX_dVAShpyeXXe9LfuHkdGkJWLxjIuK86cSYC2DZLg~9b7f648e0f439160f1d1a75d87424b97

Anstehende Termine für Albireo Pharma, Inc.

Es liegt kein Termin vor

Zurückliegende Termine für Albireo Pharma, Inc.

15.11.2022 11:20 Jefferies London Healthcare Conference
08.11.2022 22:30 Q3 2022 Präsentation des Ergebnisses
08.11.2022 Q3 2022 Ergebnisveröffentlichung Nachbörslich
07.11.2022 19:00 American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37254
07.11.2022 19:00 American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37608
07.11.2022 19:00 American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 850
07.11.2022 19:00 American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37939
07.11.2022 19:00 American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37273
06.11.2022 20:10 American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 865
06.11.2022 19:00 American Association for the Study of Liver Diseases The Liver Meeting - Abstract Meeting : 37733
18.10.2022 16:30 H.C. Wainwright Hepatitis B Virus (HBV) Conference
15.10.2022 20:00 NASPGHAN Meeting
15.10.2022 18:00 NASPGHAN Meeting - Abstract Number : 547
14.10.2022 19:45 NASPGHAN Meeting
14.10.2022 18:00 NASPGHAN Meeting - Abstract Number : 301
13.10.2022 23:00 NASPGHAN Meeting - Abstract Number : 70
11.10.2022 14:30 Bylvay Phase 3 Trial Results Call
28.09.2022 14:30 Guggenheim Therapeutics Conference
13.09.2022 14:30 Baird Global Healthcare Conference
12.09.2022 16:30 Morgan Stanley Global Healthcare Conference
  1. Börse
  2. Aktien
  3. A2DF99 Aktie
  4. Termine Albireo Pharma, Inc.